Logos Global Management LP Viracta Therapeutics, Inc. Transaction History
Logos Global Management LP
- $775 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding VIRX
# of Institutions
5Shares Held
295KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY273KShares$2,7320.0% of portfolio
-
Hoyle Cohen, LLC14KShares$1400.0% of portfolio
-
Planning Capital Management Corp Paoli, PA7.27KShares$720.0% of portfolio
-
Four Thought Financial, LLC Venice, FL500Shares$50.0% of portfolio
-
Private Ocean, LLC3Shares$00.0% of portfolio
About Viracta Therapeutics, Inc.
- Ticker VIRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,558,200
- Market Cap $376K
- Description
- Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...